Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent

por Miao, Shuang, He, Qianqian, Li, Chen, Wu, Yan, Liu, Mengshan, Chen, Yongshou, Qi, Shizhou, Gong, Kaikai
Publicado 2022

Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma

por Gong, Kaikai, Miao, Shuang, Yang, Lijuan, Wu, Yan, Guo, Jiwei, Chen, Weiwei, Dai, Juanjuan, Du, Jing, Xi, Sichuan
Publicado 2020

Repression of YAP by NCTD disrupts NSCLC progression

por Guo, Jiwei, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Li, XueLin, Xi, Sichuan
Publicado 2016

Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression

por Guo, Jiwei, Wu, Yan, Du, Jing, Yang, Lijuan, Chen, Weiwei, Gong, Kaikai, Dai, Juanjuan, Miao, Shuang, Jin, Dan, Xi, Sichuan
Publicado 2018

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells

por Guo, Jiwei, Jin, Dan, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Miao, Shuang, Xi, Sichuan
Publicado 2018

Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cel...

por Guo, Jiwei, Jin, Dan, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Miao, Shuang, Xi, Sichuan
Publicado 2021

Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment

por Du, Jing, Chen, Weiwei, Yang, Lijuan, Dai, Juanjuan, Guo, Jiwei, Wu, Yan, Gong, Kaikai, Zhang, Jian, Yu, Ning, Xie, Zhen, Xi, Sichuan
Publicado 2017

Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment

por Du, Jing, Chen, Weiwei, Yang, Lijuan, Dai, Juanjuan, Guo, Jiwei, Wu, Yan, Gong, Kaikai, Zhang, Jian, Yu, Ning, Xie, Zhen, Xi, Sichuan
Publicado 2020

LncRNA MALAT1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis

por Dai, Juanjuan, Zhou, Ning, Wu, Rui, Du, Jing, Miao, Shuang, Gong, Kaikai, Yang, Lijuan, Chen, Weiwei, Li, Xuelin, Li, Chen, Wu, Yan
Publicado 2021

Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis

por Jin, Dan, Guo, Jiwei, Wu, Yan, Chen, Weiwei, Du, Jing, Yang, Lijuan, Wang, Xiaohong, Gong, Kaikai, Dai, Juanjuan, Miao, Shuang, Li, Xuelin, Su, Guoming
Publicado 2020

m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

por Jin, Dan, Guo, Jiwei, Wu, Yan, Yang, Lijuan, Wang, Xiaohong, Du, Jing, Dai, Juanjuan, Chen, Weiwei, Gong, Kaikai, Miao, Shuang, Li, Xuelin, Sun, Hongliang
Publicado 2020

Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

por Jin, Dan, Guo, Jiwei, Wu, Yan, Yang, Lijuan, Wang, Xiaohong, Du, Jing, Dai, Juanjuan, Chen, Weiwei, Gong, Kaikai, Miao, Shuang, Li, Xuelin, Sun, Hongliang
Publicado 2022

Correction: Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis

por Jin, Dan, Guo, Jiwei, Wu, Yan, Chen, Weiwei, Du, Jing, Yang, Lijuan, Wang, Xiaohong, Gong, Kaikai, Dai, Juanjuan, Miao, Shuang, Li, Xuelin, Su, Guoming
Publicado 2022